Amanote Research
Register
Sign In
Single-Agent Thalidomide for Treatment of First Relapse Following High-Dose Chemotherapy in Patients With Multiple Myeloma
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2403564
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
October 28, 2004
Authors
R Fenk
B Hoyer
U Steidl
M Kondakci
T Graef
R Heuk
L Ruf
C Strupp
F Neumann
U-P Rohr
B Hildebrandt
R Haas
G Kobbe
Publisher
Springer Nature
